{"artifact":{"id":"experiment-exp-a87f6346-8704-4835-83d3-9cbcb4f7c196","artifact_type":"experiment","entity_ids":"[\"Cx43\"]","title":"Gap26 treatment in UAC rat model of TMJOA","quality_score":0.8,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"a94a2649625d463fb8f7dd9c6457a95abdebd945158e20a38eb9a77f8c2fc23a","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T22:49:52.054320"},"p_value":null,"protocol":"Administration of Gap26 inhibitor to UAC rats followed by assessment of TMJ degeneration, Cx43 activity, and Wnt/β-catenin signaling compared to untreated controls","effect_size":null,"sample_size":null,"source_pmid":"41757775","extracted_at":"2026-04-10T15:49:51.837938","_schema_version":1,"experiment_type":"animal_model","success_criteria":"Demonstration of reduced cartilage degeneration, decreased Cx43 activity, and suppressed Wnt/β-catenin signaling compared to untreated UAC controls","expected_outcomes":"Gap26 treatment would reduce TMJ degeneration and suppress pathological signaling pathways","statistical_methods":null},"created_at":"2026-04-10T22:49:52-07:00","updated_at":"2026-04-10T22:49:52-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T22:49:52-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"deeeb0d1-ae3f-4b2a-ab82-173ec183b20a","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"experiment-exp-dd170ed1-e7d7-41dc-ba80-5cd1453be1e2","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-d6c48a0b-9631-49bc-a83f-51211242cd04","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-c10a5471-3d00-4106-923c-6d5c7de8868a","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-8288f904-6ab6-4bbe-b9db-9855b5abbd8d","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"}],"incoming_links":[{"source_artifact_id":"experiment-exp-8288f904-6ab6-4bbe-b9db-9855b5abbd8d","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-dd170ed1-e7d7-41dc-ba80-5cd1453be1e2","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-d6c48a0b-9631-49bc-a83f-51211242cd04","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-c10a5471-3d00-4106-923c-6d5c7de8868a","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"}],"current_artifact_id":"experiment-exp-a87f6346-8704-4835-83d3-9cbcb4f7c196","is_canonical":true,"supersede_chain":["experiment-exp-a87f6346-8704-4835-83d3-9cbcb4f7c196"]}